Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism

Fig. 7

AVN-C treatment activates caspases 3/7. a Representative sample of flow cytometric analysis of cells treated with CellEvent Caspase-3/7 Green Flow Cytometric Assay Kit to detect caspase activity (Comp-FL1-A) and dead cells (Comp-FL3-A) after treatment with DMSO 0.4% (vehicle), AVN-A, B, C at 400 µM, or STS for 96 h. b Graphical representation of the percentage of cells in each quadrant after staining. Results are a biological replicate done in triplicate. * Indicates statistical significance difference from 0.4% DMSO negative control for each individual quadrant as determined by a t test at p < 0.05 level of significance, ** indicates significance level at p < 0.01, *** indicates significance at p < 0.001 level

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us